ReviewDrugs2013

Brentuximab vedotin: a review of its use in patients with hodgkin lymphoma and systemic anaplastic large cell lymphoma following previous treatment failure.

Karly P Garnock-JonesPubMed ↗Publisher ↗

No numbers read from the abstract.